Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
H. Aburatani
Leukemia, 2013
View PDFchevron_right
Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy
Florian Nolte
Experimental Hematology, 2009
View PDFchevron_right
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
Bicky Thapa
Cells
View PDFchevron_right
TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes
Francesc Solé
Oncotarget, 2015
View PDFchevron_right
Whole Exome Sequencing or Pan-Myeloid NGS Gene Panel to Assess Leukemic Evolution of Myelodysplastic Syndromes. Advantages and Disadvantages
BJSTR Angela Roy
BJSTR, 2022
View PDFchevron_right
Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays
Aristoteles Giagounidis
Haematologica, 2008
View PDFchevron_right
The genomic landscape of pediatric myelodysplastic syndromes
Raul Ribeiro
Nature communications, 2017
View PDFchevron_right
Lack of association between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndrome
João A Machado-Neto
Neoplasma, 2012
View PDFchevron_right
Myelodysplastic syndromes: an update on molecular pathology
Marisa Calabuig
Clinical and Translational Oncology, 2010
View PDFchevron_right
Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights
Mohammad Shahjahani
Oncology reviews, 2016
View PDFchevron_right
Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
M. Larrayoz
Leukemia, 2013
View PDFchevron_right
Global gene expression profile in myelodysplastic syndromes using SAGE
Claudia Regina Bonini Domingos
Genetics and Molecular Research, 2008
View PDFchevron_right
Genetics factors associated with myelodysplastic syndromes
camila rodrigues
Blood Cells, Molecules, and Diseases, 2015
View PDFchevron_right
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
J Hayden
Blood, 2007
View PDFchevron_right
Additional information offered by single nucleotide polymorphism (SNP) array advantages in two myelodysplastic syndromes with excess blasts (MDS-EB) cases and future perspectives
Maria de Lourdes Chauffaille
Hematology, Transfusion and Cell Therapy
View PDFchevron_right
Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes
Emiliano Fabiani
Inflammation Research, 2023
View PDFchevron_right
Gene Predisposes to High-Risk Myelodysplastic Syndrome
Werner Emberger
2005
View PDFchevron_right
Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes
Anne-Christin Hauschild
BMC Medical Genomics, 2011
View PDFchevron_right
New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes
Khalid Afaneh
American Society of Clinical Oncology Educational Book, 2017
View PDFchevron_right
Invariant Patterns of Clonal Succession Determines Specific Phenotypic and Clinical Features of Myelodysplastic Syndromes (MDS)
fahad Asad
Blood, 2018
View PDFchevron_right
Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms
Cassandra Hirsch
International journal of hematology, 2015
View PDFchevron_right
Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes
Susanne Schnittger
Haematologica, 2017
View PDFchevron_right
Genomic variations in patients with myelodysplastic syndrome and karyotypes without numerical or structural changes
Irene Pinto
Scientific Reports
View PDFchevron_right
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing
Giuliana Palazzo
Journal of Hematology & Oncology
View PDFchevron_right
5q- myelodysplastic syndromes The molecular signature of MDS stem cells supports a stem cell origin of
Patrik Edén
2010
View PDFchevron_right
Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response
stavroula siamoglou
Human Genomics
View PDFchevron_right
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
Austin Kulasekararaj
Blood, 2011
View PDFchevron_right
Targeted re-sequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression
Anna Schuh
Leukemia, 2015
View PDFchevron_right
Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration
TZU HUA CHEN LIANG
Journal of Clinical Medicine, 2021
View PDFchevron_right